OTCMKTS:CGNH - CardioGenics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0169 0.00 (0.00 %) (As of 04/19/2019 04:00 PM ET)Previous Close$0.0169Today's Range$0.0130 - $0.016952-Week Range$0.0048 - $0.04Volume24,400 shsAverage Volume88,263 shsMarket Capitalization$1.96 millionP/E RatioN/ADividend YieldN/ABeta-2.21 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada. Receive CGNH News and Ratings via Email Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CGNH Previous Symbol CUSIPN/A CIK1089029 Webwww.cardiogenics.com Phone905-673-8501Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees4 Outstanding Shares116,185,000Market Cap$1.96 million Next Earnings DateN/A OptionableNot Optionable CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions What is CardioGenics' stock symbol? CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH." Has CardioGenics been receiving favorable news coverage? Media headlines about CGNH stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CardioGenics earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the next several days. Who are some of CardioGenics' key competitors? Some companies that are related to CardioGenics include ITEX (ITEX), China Recycling Energy (CREG), Accelerize (ACLZ), Janel (JANL), ICTS International (ICTSF), International Monetary Systems (ITNM), Live Current Media (LIVC), Dale Jarrett Racing Adventure (TVMD), Sparta Commercial Services (SRCO), Invictus Financial (IVFZF), LiveWorld (LVWD), Prism Technologies Group (PRZM), MoneyOnMobile (MOMT), Hydrophi Technologies Group (HPTG) and RightsCorp (RIHT). What other stocks do shareholders of CardioGenics own? Based on aggregate information from My MarketBeat watchlists, some companies that other CardioGenics investors own include Trinity Biotech (TRIB), Rock Creek Pharmaceuticals (RCPIQ) and Canopy Growth (CGC). Who are CardioGenics' key executives? CardioGenics' management team includes the folowing people: Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 61)Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 70)Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 58) How do I buy shares of CardioGenics? Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CardioGenics' stock price today? One share of CGNH stock can currently be purchased for approximately $0.0169. How big of a company is CardioGenics? CardioGenics has a market capitalization of $1.96 million. CardioGenics employs 4 workers across the globe. What is CardioGenics' official website? The official website for CardioGenics is http://www.cardiogenics.com. How can I contact CardioGenics? CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected] MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)Community Ranking: 3.2 out of 5 ( )Outperform Votes: 54 (Vote Outperform)Underperform Votes: 30 (Vote Underperform)Total Votes: 84MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/20/2019 by MarketBeat.com StaffFeatured Article: Why do company’s buyback their stock?